Cross-linked collagen comprising an antifungal agent

US8940684B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-8940684-B2
Application numberUS-201313815775-A
CountryUS
Kind codeB2
Filing dateMar 15, 2013
Priority dateNov 19, 2012
Publication dateJan 27, 2015
Grant dateJan 27, 2015

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The disclosure describes collagen constructs comprising antifungal agents, preferably, copper, and related methods.

First claim

Opening claim text (preview).

The invention claimed is: 1. An antifungal cross-linked collagen construct comprising: a cross-linked collagen comprising collagen and one or more cross-linking agents and an antifungal amount of copper incorporated into the construct, wherein at least a portion of the copper is chelated to one or more of the cross-linking agents, and at least another portion of the copper is bound to the construct via one or more of covalent, non-covalent, ionic, and metallic bonds.…

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Next steps

Free tools are coming soon. Tell us what you want to track and we'll notify you.

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US8940684B2 cover?
The disclosure describes collagen constructs comprising antifungal agents, preferably, copper, and related methods.
Who is the assignee on this patent?
Mimedx Group Inc
What technology area does this patent fall under?
Primary CPC classification A61K47/42. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).